[1] O’BRIEN J T, THOMAS A. Vascular dementia[J]. Lancet, 2015, 386(10 004): 1698 - 1706 . doi: 10.1016/S0140-6736(15)00463-8
[2] O’BRIEN J T, ERKINJUNTTI T, REISBERG B, ROMAN G, SAWADA T, PANTONI L, BOWLER J V, BALLARD C, DeCARLI C, GORELICK P B, ROCKWOOD K, BURNS A, GAUTHIER S, DeKOSKY S T. Vascular cognitive impairment[J]. The Lancet Neurology, 2003, 2(2): 89 - 98 . doi: 10.1016/S1474-4422(03)00305-3
[3] IADECOLA C. The pathobiology of vascular dementia[J]. Neuron, 2013, 80(4): 844 - 866 . doi: 10.1016/j.neuron.2013.10.008
[4] CALABRESE V, GIORDANO J, SIGNORILE A, ONTARIO M L, CASTORINA S, de PASQUALE C, ECKERT G, CALABRESE E J. Major pathogenic mechanisms in vascular dementia: roles of cellular stress response and hormesis in neuroprotection[J]. Journal of Neuroscience Research, 2016, 94(12): 1588 - 1603 . doi: 10.1002/jnr.23925
[5] ALAM R, TRIPATHI M, MANSOORI N, PARVEEN S, LUTHRA K, LAKSHMY R, SHARMA S, ARULSELVI S, MUKHOPADHYAY A K. Synergistic epistasis of paraoxonase 1 (rs662 and rs85460) and apolipoprotein E4 genes in pathogenesis of Alzheimer’s disease and vascular dementia[J]. American Journal of Alzheimer’s Disease and Other Dementias, 2014, 29(8): 769 - 776 . doi: 10.1177/1533317514539541
[6] 郭欣, 林珊, 吴丽明, 田新慧. 灯盏细辛化学成分及药理作用研究进展[J]. 中成药, 2019, 41(2): 393 - 402 . doi: 10.3969/j.issn.1001-1528.2019.02.030 GUO Xin, LIN Shan, WU Liming, TIAN Xinhui. Research progress on chemical constituents and pharmacological effects of Erigeron Breviscapus[J]. Chinese Traditional Patent Medicine, 2019, 41(2): 393 - 402 (in Chinese). doi: 10.3969/j.issn.1001-1528.2019.02.030
[7] GUO L L, DENG J, WANG Y L, HUANG Y, GUAN Z Z. Influence of scutellarin on oxidative stress and neuronal apoptosis of rats with dementia[J]. Zhong Yao Cai, 2011, 34(2): 237 - 241 .
[8] 郭婷, 黎元元. 灯盏细辛注射液药理和毒理作用研究进展[J]. 中国中药杂志, 2012, 37(18): 2820 - 2823 . GUO Ting, LI Yuanyuan. Progresses on pharmacological and toxicological effects of Dengzhanxixin injection[J]. China Journal of Chinese Materia Medica, 2012, 37(18): 2820 - 2823 (in Chinese).
[9] WU R, LIANG Y, XU M, FU K, ZHANG Y, WU L, WANG Z. Advances in chemical constituents, clinical applications, pharmacology, pharmacokinetics and toxicology of erigeron breviscapus[J]. Frontiers in Pharmacology, 2021, 12: 656335 . doi: 10.3389/fphar.2021.656335
[10] CHAI L, GUO H, LI H, WANG S, WANG Y L, SHI F, HU L M, LIU Y, ADAH D. Scutellarin and caffeic acid ester fraction, active components of Dengzhanxixin injection, upregulate neurotrophins synthesis and release in hypoxia/reoxygenation rat astrocytes[J]. Journal of Ethnopharmacology, 2013, 150(1): 100 - 107 . doi: 10.1016/j.jep.2013.08.011
[11] 郭欣. 灯盏细辛注射液化学成分及药代动力学研究[D]. 上海: 上海中医药大学, 2019.
[12] 史金新. 灯盏细辛注射液中野黄芩苷的大鼠药代动力学研究[D]. 上海: 上海应用技术大学, 2020.
[13] XIE X, WANG F, GE W, MENG X, FAN L, ZHANG W, WANG Z, DING M, GU S, XING X, SUN X. Scutellarin attenuates oxidative stress and neuroinflammation in cerebral ischemia/reperfusion injury through PI3K/Akt-mediated Nrf2 signaling pathways[J]. European Journal of Pharmacology, 2023, 957: 175979 . doi: 10.1016/j.ejphar.2023.175979
[14] SAKTHIVEL K M, VISHNUPRIYA S, PRIYA DHARSHINI L C, RASMI R R, RAMESH B. Modulation of multiple cellular signalling pathways as targets for anti-inflammatory and anti-tumorigenesis action of Scopoletin[J]. The Journal of Pharmacy and Pharmacology, 2022, 74(2): 147 - 161 . doi: 10.1093/jpp/rgab047
[15] SINGH V K, SAHOO D, AGRAHARI K, KHAN A, MUKHOPADHYAY P, CHANDA D, YADAV N P. Anti-inflammatory, anti-proliferative and anti-psoriatic potential of apigenin in RAW 264.7 cells, HaCaT cells and psoriasis like dermatitis in BALB/c mice[J]. Life Sciences, 2023, 328: 121909 . doi: 10.1016/j.lfs.2023.121909
[16] DENG M, SUN J, PENG L, HUANG Y, JIANG W, WU S, ZHOU L, CHUNG S K, CHENG X. Scutellarin acts on the AR-NOX axis to remediate oxidative stress injury in a mouse model of cerebral ischemia/reperfusion injury[J]. Phytomedicine, 2022, 103: 154214 . doi: 10.1016/j.phymed.2022.154214
[17] GAO X Y, LI X Y, ZHANG C Y, BAI C Y. Scopoletin: a review of its pharmacology, pharmacokinetics, and toxicity[J]. Frontiers in Pharmacology, 2024, 15: 1268464 . doi: 10.3389/fphar.2024.1268464
[18] AN H, TAO W, LIANG Y, LI P, LI M, ZHANG X, CHEN K, WEI D, XIE D, ZHANG Z. Dengzhanxixin injection ameliorates cognitive impairment through a neuroprotective mechanism based on mitochondrial preservation in patients with acute ischemic stroke[J]. Frontiers in Pharmacology, 2021, 12: 712436 . doi: 10.3389/fphar.2021.712436
[19] LI M, MENG N, GUO X, NIU X, ZHAO Z, WANG W, XIE X, LV P. Dl-3-n-butylphthalide promotes remyelination and suppresses inflammation by regulating AMPK/SIRT1 and STAT3/NF-κB signaling in chronic cerebral hypoperfusion[J]. Frontiers in Aging Neuroscience, 2020, 12: 137 . doi: 10.3389/fnagi.2020.00137
[20] CHAN D K, SRINIVASAN V, UPTON C, CHEN X, ROMERO-ORTUNO R. The association between frailty and vascular dementia[J]. Chinese Journal of Geriatrics, 2015, 34(12): 1 293-1 299.
[21] 陈英华, 孙忠人, 金弘, 洪霞, 姜磊, 秦瑞奇, 魏巍, 倪国忠. 针刺对血管性痴呆大鼠血清TNF-α、IL-1β及学习记忆能力的影响[J]. 针灸临床杂志, 2013, 29(5): 56 - 60 . doi: 10.3969/j.issn.1005-0779.2013.05.022 CHEN Yinghua, SUN Zhongren, JIN Hong, HONG Xia, JIANG Lei, QIN Ruiqi, WEI Wei, NI Guozhong. Effects of acupuncture on the levels of TNF-α and IL-1β in serum and on the learning and memory ability of vascular dementia rats[J]. Journal of Clinical Acupuncture and Moxibustion, 2013, 29(5): 56 - 60 (in Chinese). doi: 10.3969/j.issn.1005-0779.2013.05.022
[22] 陈欣悦, 边文超, 赵晴, 许卓. MAPK信号通路在血管性痴呆中研究进展[J]. 中国老年学杂志, 2023, 43(5): 1267 - 1270 . doi: 10.3969/j.issn.1005-9202.2023.05.065 CHEN Xinyue, BIAN Wenchao, ZHAO Qing, XU Zhuo. Research progress of MAPK signaling pathway in vascular dementia[J]. Chinese Journal of Gerontology, 2023, 43(5): 1267 - 1270 (in Chinese). doi: 10.3969/j.issn.1005-9202.2023.05.065
[23] CHEN H L, JIA W J, LI H E, HAN H, LI F, ZHANG X L N, LI J J, YUAN Y, WU C Y. Scutellarin exerts anti-inflammatory effects in activated microglia/brain macrophage in cerebral ischemia and in activated BV-2 microglia through regulation of MAPKs signaling pathway[J]. Neuromolecular Medicine, 2020, 22(2): 264 - 277 . doi: 10.1007/s12017-019-08582-2
[24] YUAN Z, MO Y, LI D, XIE L, CHEN M. Inhibition of ERK downregulates autophagy via mitigating mitochondrial fragmentation to protect SH-SY5Y cells from OGD/R injury[J]. Cell Communication and Signaling, 2023, 21(1): 204 . doi: 10.1186/s12964-023-01211-3
[25] 杨洋, 刘晓楠, 马超, 姜源, 孙晓红. ERK1/2信号传导通路在大鼠局灶性急性脑缺血再灌注中的作用[J]. 中国动脉硬化杂志, 2013, 21(11): 987 - 992 . YANG Yang, LIU Xiaonan, MA Chao, JIANG Yuan, SUN Xiaohong. The effect of ERK1/2 signal transduction pathway in rats focal acute ischemia-reper-fusion[J]. Chinese Journal of Arteriosclerosis, 2013, 21(11): 987 - 992 (in Chinese).
[26] 谢惠芳, 徐如祥, 魏继鹏, 刘振华, 姜晓丹. JAK2/STAT3信号转导通路在缺血性脑损伤中作用机制的研究[J]. 中风与神经疾病杂志, 2008, 25(2): 135 - 138 . doi: 10.3969/j.issn.1003-2754.2008.02.002 XIE Huifang, XU Ruxiang, WEI Jipeng, WEI Jipeng, LIU Zhenhua, JIANG Xiaodan. The mechanisms of JAK2/STAT3 signal pathway in ischemic brain injury in rats[J]. Journal of Apoplexy and Nervous Diseases, 2008, 25(2): 135 - 138 (in Chinese). doi: 10.3969/j.issn.1003-2754.2008.02.002
[27] SINGH A A, YADAV D, KHAN F, SONG M. Indole-3-carbinol and its derivatives as neuroprotective modulators[J]. Brain Sciences, 2024, 14(7): 674 . doi: 10.3390/brainsci14070674
[28] FAN X, WU J, YANG H, YAN L, WANG S. Paeoniflorin blocks the proliferation of vascular smooth muscle cells induced by platelet-derived growth factor-BB through ROS mediated ERK1/2 and p38 signaling pathways[J]. Molecular Medicine Reports, 2018, 17(1): 1676 - 1682 .